In the predicted mature C-terminal portion of the moleInhibin-bC is a recently described TGF-b family cule, inhibin-bC was found to be most homologous to member most homologous to inhibin-bA and inhibin-inhibin-bA and inhibin-bB (51 and 53% amino acid bB. By Northern analysis, inhibin-bC mRNA was de-identity, respectively). Moreover, the C-terminal region tected exclusively in the liver among a large number of inhibin-bC contained a nine cysteine pattern typical of adult mouse tissues surveyed. The expression of in-of the inhibin-bs and TGF-bs. Although this new family hibin-bC mRNA in adult liver dropped sharply and member was given the name inhibin-bC on the basis transiently following partial hepatectomy. At 6 and 12 of its sequence relatedness to the other inhibin-b sub- TGF-b superfamily are known to be capable of regulating hepatocyte proliferation (6-10), we examined the expression pattern of inhibin-bC in various murine The transforming growth factor-b superfamily en-models of liver injury. Here, we report that inhibin-bC compasses a large number of growth and differentia-is dramatically and transiently down-regulated followtion factors involved in regulating a wide range of dif-ing partial hepatectomy. This observation taken toferentiation processes occurring during embryonic de-gether with the known inhibitory effects of other memvelopment and in adult tissues (for review, see ref. 1). bers of the TGF-b superfamily on hepatocyte proliferaWhile the specific roles played by some of these family tion raises the possibility that inhibin-bC may members have been elucidated through both in vitro normally be involved in maintaining liver cells in and in vivo studies, the biological activities of many of growth arrest. these family members, particularly those identified on the basis of their homology to other family members, MATERIALS AND METHODS are currently unknown. Hotten et al. (2) recently reported the identification of a novel TGF-b family memMice. All mouse studies were carried out using the strain CD-1 (Charles River) and were conducted in accord with the guidelines for ber that they designated inhibin-bC. Inhibin-bC was care and use of experimental animals. Mice were anesthesized with isolated from human liver cDNA by degenerate PCR methoxyflurane prior to surgery. Partial hepatectomies were carried using primers corresponding to conserved regions out by resecting the left lateral and medial lobes as described preamong known family members. Sequence analysis of viously (12). Ligation of the common bile duct was carried out as described previously (13). To induce proliferation of oval cells, Dan inhibin-bC cDNA clone revealed an overall strucgalactosamine was administered at a single dose of 17.5 mg as de-
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Northern analysis and isolation and characterization of cDNA clones.
A murine inhibin-bC clone was isolated by screening a liver 1 These authors contributed equally to this work. 2 Present address: Georgetown University Medical Center, Pas-cDNA library with a probe derived from a related gene, GDF-12.
GDF-12 was originally isolated from embryonic cDNA by PCR using querilla Health Care Center, 38 Reservoir Rd., 4th floor, Washington, DC 20007.
degenerate primers corresponding to regions conserved among known members of the TGF-b superfamily (A. Esquela and S.-J. Lee, 3 To whom correspondence should be addressed.
unpublished results). The isolation and characterization of GDF-12 will be described elsewhere. From one million recombinant phage screened with a GDF-12 probe, two inhibin-bC clones were identified. Nucleotide sequence analysis of the longer inhibin-bC cDNA clone revealed a single long open reading frame beginning with a methionine codon at nucleotide 90 and ending with a TAG termination codon at nucleotide 1146. The open reading frame contained in the sequence predicts a protein 352 amino acids in length. RNA was isolated by homogenization of tissues in guanidine thiocyanate and centrifugation through a cesium chloride cushion, as described previously (15). Isolation of poly A-containing RNA was carried out as described previously (15). Northern analysis was carried out as described previously (16).
RESULTS AND DISCUSSION
To determine the expression pattern of inhibin-bC, we screened by Northern analysis a variety of adult mouse tissues for the presence of inhibin-bC mRNA. As shown in Figure 1a , inhibin-bC mRNA was detected exclusively in the liver among a large number of adult tissues surveyed. No inhibin-bC mRNA could be detected in the other tissues even upon prolonged exposure of this blot (data not shown). Inhibin-bC mRNA was also detected in mouse embryos, and as in adult animals, the expression of inhibin-bC mRNA in embryos also appeared to be liver specific (Figure 1b) . The levels of inhibin-bC mRNA increased during liver development with the highest levels being detected in the early post-natal period (Figure 2) . Hence, inhibin-bC appears to play a regulatory role in both embryonic and adult liver.
To begin to understand the specific role that inhibinbC plays in adult animals, we examined the expression pattern of inhibin-bC in various models of liver injury. As shown in Figure 3 , the levels of inhibin-bC mRNA showed a dramatic transient drop at 6 and 12 hours following partial hepatectomy. Based on a quantitation of these data using a phosphorimager, we estimate that inhibin-bC mRNA levels were at least 8-fold lower at the levels appeared to be relatively constant. The downmicrograms of once-poly A-selected RNA isolated from day 12.5, day regulation of inhibin-bC expression did not appear to 14.5, or day 18.5 (lanes 5 and 6) whole mouse embryos (lanes 1 and result simply from the trauma of surgery as the levels 3) or mouse embryos from which the liver had been removed and of inhibin-bC mRNA were unchanged in sham-oper-discarded. ated animals (data not shown). Moreover, the levels of inhibin-bC mRNA appeared to be relatively constant in livers isolated from animals at three hour intervals hibit proliferation of hepatocytes. Although much is known about the factors that play important stimulaspaced throughout the day and night (data not shown). Hence, we do not believe that the down-regulation of tory roles for liver growth (for reviews, see refs. 17, 18), little is known about the factors that function to inhibit inhibin-bC expression simply reflected diurnal variation. Finally, inhibin-bC levels appeared to be un-hepatocyte growth. At least two molecules have been shown to be capable of inhibiting hepatocyte proliferachanged following treatment with D-galactosamine (data not shown), which results in proliferation of oval tion in vitro and in vivo. One of these is TGF-b, which is known to be a potent growth inhibitor for a variety cells, bile duct cells, and small hepatocytes (14), or following common bile duct ligation (data not shown), of cell types (for review, see ref. 19) , and the other is activin A, which is related in sequence to TGF-b (for which results in proliferation of bile duct cells (13).
The regulation of liver size is believed to be mediated review, see ref. 1). In addition to being structurally related, TGF-b and activin A share a number of characby secreted factors that act to either stimulate or in-sized specifically by liver cells that inhibits hepatocyte proliferation (26). Because liver regeneration could also be inhibited by injection of plasma from normal animals but not from animals that had undergone partial hepatectomy (27), the hepatic chalone was hypothesized to be a circulating factor. According to this hypothesis, the circulating levels of the hepatic chalone drop following partial hepatectomy, thereby releasing hepatocytes from growth arrest (26). The identity of the hepatic chalone, if indeed such a molecule exists, is currently unknown. Although TGF-b and activin A have been proposed to be candidates for the hepatic chalone, the lack of tissue specificity of expression of these molecules would seem to make this possibility unlikely.
Here, we report the liver-specific expression of another molecule related to TGF-b and activin A, namely inhibin-bC. Inhibin-bC mRNA levels are dramatically down-regulated following partial hepatectomy. To our knowledge, inhibin-bC is the only gene reported thus far to show such a dramatic down-regulation in this liver injury model. The down-regulation of inhibin-bC expression following partial hepatectomy contrasts sharply with the regulation of TGF-b and activin A, which are both up-regulated. Our findings suggest that inhibin-bC may function as a growth inhibitor that must be cleared in order for the regenerative response to take place. The down-regulation of inhibin-bC ex- teristics regarding their effects on hepatocytes and their expression patterns in the liver. First, both TGFb and activin A are growth inhibitory for primary hepatocytes in culture and can inhibit the mitogenic response to both EGF and HGF (6-11). Second, both TGFb and activin A can induce apoptosis of hepatocytes when administered to animals (20, 21). In this regard, animals carrying a targeted disruption of the inhibina gene have been shown to develop hepatocellular necrosis, presumably as a result of overstimulation by activin (22) . And third, both TGF-b and activin A mRNA levels are up-regulated in the liver following partial hepatectomy in the rat (11, 23, 24) . Based on these properties of TGF-b and activin A, these molecules have been proposed to play a role in terminating the regenerative response following liver injury.
Even less is known about the factors that may be hypothesized the existence of a hepatic chalone synthe- 
